Alverina Pydynkowski

Alverina Pydynkowski is a seasoned professional in biomarker operations and translational medicine, currently serving as the Manager of Biomarker Operations at Blueprint Medicines since June 2022. Prior to this role, Alverina held various positions at Constellation Pharmaceuticals, where responsibilities included authoring clinical protocols and managing collaborations for biomarker assay development, and at Moderna, focusing on T-Cell assays for personalized cancer vaccines. Earlier experience includes research roles at Genocea Biosciences and an internship with the Massachusetts Department of Public Health, concentrating on data analysis related to postpartum depression. Alverina holds a Master of Public Health degree in Epidemiology and Biostatistics from Tufts University School of Medicine and a Bachelor of Science in Biology from Gordon College, as well as a certificate in Immunology from Harvard Medical School's online program.